In November, drug giant Johnson & Johnson (J&J) and its subsidiaries agreed to pay $2.2 billion in fines and fees for wrongdoing related to kickbacks and misbranding of a number of their medications.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.